Yooyoung Pharmaceutical Co., Ltd.
22
0
0
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
4.5%
1 terminated/withdrawn out of 22 trials
92.9%
+6.4% vs industry average
41%
9 trials in Phase 3/4
0%
0 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
Post Marketing Clinical Follow up Study of HyaleXo
Role: lead
To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients
Role: collaborator
Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients
Role: lead
Clinical Trial of YYC301 P3 for Treatment of Osteoarthritis of the Knee
Role: lead
Post Marketing Clinical Follow up Study to Evaluate the Performance and Safety of ORTHIX PLUS
Role: lead
Post Marketing Clinical Follow up Study to Evaluate the Performance and Safety of HYALEXO
Role: lead
Clinical Trial to Assess the Efficacy and Safety of YYD601 in the Treatment of Esophageal Reflux Disease (ERD)
Role: lead
Evaluate the Efficacy and Safety of Short-term Administration of SIMDAX
Role: lead
Clinical Trial to Assess the PK/PD of YYD601 20mg After Oral Administration if Healthy Adult Subjects (Phase1)
Role: lead
Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee
Role: lead
Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients
Role: lead
Clinical Trial of YYD302 (Phase3) for Treatment of Osteoarthritis of the Knee
Role: lead
Clinical Trial of YYD701-2 for Treatment of Nasolabial Folds
Role: lead
Phase 1 to Evaluate the Safety and Pharmacokinetic Characteristics of Fixed-dose Combination of YYC506
Role: lead
Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A
Role: lead
Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506.
Role: lead
Clinical Trial to Evaluate the Efficacy and Safety of Pravafenix Cap to Verify the Superiority Than Atorvastatin
Role: lead
PK/PD Clinical Trial of YYD601 in Healthy Adult Male
Role: lead
Clinical Trial of YYD302 for Treatment of Osteoarthritis of the Knee
Role: lead
Prospective Observational Study of Pravafenix Cap
Role: lead